2 studies found for:    19273710 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane
Condition: Unresectable Locally Advanced Pancreatic Carcinoma
Intervention: Device: OncoSil™
2 Recruiting Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Targeted chemotherapy prior to surgery;   Drug: standard FOLFIRINOX chemotherapy prior to surgery;   Drug: Gemcitabine after surgery;   Other: No additional therapy after surgery;   Drug: Targeted chemotherapy after surgery;   Radiation: Chemoradiotherapy (cXRT)

Study has passed its completion date and status has not been verified in more than two years.